“Overall survival and role of programmed death ligand 1 expression in patients with metastatic non-small-cell lung cancer and immunotherapy: an observational study from central Switzerland” (2023) Swiss Medical Weekly, 153(1), p. 40039. doi:10.57187/smw.2023.40039.